However, there have been reports of inhibition of cancer metastasis, including in vivo, using MITF inhibitor [49], MCAM antibodies [50,51], and miRNA targeting MCAM [52,53]; it is hoped that inhibition of the MITF/MCAM axis will inhibit metastasis of ovarian cancer. This evidence concerns the gene MCAM and ovarian cancer.